Health How Much Upside is Left in Exact Sciences (EXAS)? Wall Street Analysts Think 34% December 13, 2022
Biotechnology Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting December 13, 2022
Health SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Horizon Therapeutics plc (HZNP) December 12, 2022
Health SHAREHOLDER ALERT: Weiss Law Investigates Horizon Therapeutics Public Limited Company December 12, 2022